Filter
141
Text search:
National
Pharmacovigilance
and
Medicines
Information
Center
Featured
Recommendations
18
New Publications
43
Language
Document type
No document type
80
Studies & Reports
22
Guidelines
21
Manuals
9
Training Material
3
Situation Updates
3
Strategic & Response Plan
2
Fact sheets
1
Countries / Regions
Ethiopia
8
Rwanda
7
Namibia
7
Nigeria
5
Ghana
5
India
5
Cambodia
5
Liberia
4
Nepal
4
Zambia
4
Kenya
4
Tanzania
3
Latin America and the Carribbean
3
Eastern Europe
3
Sierra Leone
2
Uganda
2
Philippines
2
Indonesia
2
South Africa
2
Bangladesh
2
Mozambique
2
Ukraine
2
Botswana
2
West and Central Africa
2
South–East Asia Region
2
Western and Central Europe
2
Asia
2
Africa
2
Russia
2
Cameroon
1
Zimbabwe
1
Haiti
1
Pakistan
1
Jordan
1
Afghanistan
1
Thailand
1
Malawi
1
Argentina
1
Libya
1
Lesotho
1
Sri Lanka
1
East and Southern Africa
1
Middle East and North Africa
1
Bhutan
1
Laos
1
Georgia
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
73
Clinical Guidelines
16
Capacity Building
2
Public Health
2
Women & Child Health
2
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
Pharmacy
17
TB
16
AMR
15
COVID-19
10
HIV
6
NTDs
5
Ebola
2
Refugee
2
Rapid Response
1
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicin
...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, poli
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda ha
...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that
...
Accessed November, 2017
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microo
...
The Health Sector Policy gives general orientations for the sector which are further developed in the various sub-sector policies guiding key health programs and departments. All health sub-sector policies will be updated in line with this new polic
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and
...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and
...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to m
...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t
...
